CausalSentinel

Protein Dossier — CFHR5 (Complement factor H-related protein 5)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: deep venous thrombosis (dvt) -0.0996 0.0334 0.0029 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: deep venous thrombosis (dvt) -0.0996 0.0334 0.0029 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R55 Syncope and collapse 0.111 0.0405 0.00624 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: R55 Syncope and collapse 0.111 0.0405 0.00624 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine 0.0711 0.028 0.0109 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine 0.0711 0.028 0.0109 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis -0.158 0.0736 0.0314 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: I80 Phlebitis and thrombophlebitis -0.158 0.0736 0.0314 Inverse variance weighted 2 trans NA
Vascular or heart problems diagnosed by doctor: Angina 0.0445 0.0229 0.0515 Inverse variance weighted 2 cis NA
Vascular or heart problems diagnosed by doctor: Angina 0.0445 0.0229 0.0515 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: M23 Internal derangement of knee -0.0593 0.0305 0.0516 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: M23 Internal derangement of knee -0.0593 0.0305 0.0516 Inverse variance weighted 2 trans NA
…and 86 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3666_17_4 complement factor H-related 5 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

65 association rows across 33 traits (61 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Coagulation factor XIII levels 8e-391 rs10922151 3 GCST90247104 no MR -> candidate analysis
Platelet-derived growth factor receptor alpha levels 4e-385 rs79801780 2 GCST90248912 no MR -> candidate analysis
CFHR5 protein levels 2e-305 rs34187357 3 GCST90468728 no MR -> candidate analysis
Serum levels of protein PDGFRA 1e-256 rs35662416 1 GCST90086244 no MR -> candidate analysis
Age-related macular degeneration (MTAG) 2e-157 rs12116643 1 GCST010284 no MR -> candidate analysis
Complement factor H-related protein 5 levels 2e-146 rs79801780 5 GCST90246996 no MR -> candidate analysis
F13B protein levels 5e-142 rs115844193 7 GCST90469167 no MR -> candidate analysis
Platelet-derived growth factor receptor alpha levels (PDGFRA 4e-121 rs35662416 1 GCST90242290 no MR -> candidate analysis
Serum levels of protein F13B 2e-106 rs10801583 1 GCST90089128 no MR -> candidate analysis
Coagulation factor XIII B chain levels 6e-86 rs10801582 2 GCST90247105 no MR -> candidate analysis
CFHR4 protein levels 8e-78 rs115988764 4 GCST90468727 no MR -> candidate analysis
Serum levels of protein CFHR5 2e-75 rs35662416 1 GCST90088484 no MR -> candidate analysis
…and 21 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 143 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
C3 glomerulonephritis 0.709 established (curated) no MR -> candidate analysis
chronic kidney disease 0.243 established (curated) no MR -> candidate analysis
primary membranoproliferative glomerulonephritis 0.688 established (curated) no MR -> candidate analysis
age-related macular degeneration 0.723 common-variant locus no MR -> candidate analysis
macular degeneration 0.759 common-variant locus no MR -> candidate analysis
retinal disorder 0.597 common-variant locus no MR -> candidate analysis
degeneration of macula and posterior pole 0.469 common-variant locus no MR -> candidate analysis
placental retention 0.458 common-variant locus no MR -> candidate analysis
lymphatic system disorder 0.394 common-variant locus no MR -> candidate analysis
dense deposit disease 0.316 established (curated) no MR -> candidate analysis
hereditary disease 0.317 established (curated) no MR -> candidate analysis
atypical hemolytic-uremic syndrome 0.286 established (curated) no MR -> candidate analysis
dry age related macular degeneration 0.199 common-variant locus no MR -> candidate analysis
wet macular degeneration 0.114 common-variant locus no MR -> candidate analysis
kidney disorder 0.018 established (curated) no MR -> candidate analysis

Of the 15 rows above, 15 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint pLI=1e-28, LOEUF=1.41 — LoF-tolerant
GWAS Catalog 109 unique SNPs / 250 rows
ClinVar 402 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance